Philip H. Coelho, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 15,000 shares at $0.75 ($11K) on 2016-06-17, disclosed to the SEC on 2016-06-20.
Open-market purchase of $11k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 1,700 | $1K | 11.2% |
| 2 | $0.76 | 13,300 | $10K | 88.8% |
| Total | $0.76 avg | 15,000 | $11K | 100% |
| Filing → |
| CPRX | SELL | 2021-08-26 | $264K | — | Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |